Importance of biofilm in Candida parapsilosis and evaluation of its susceptibility to antifungal agents by colorimetric method

Folia Microbiologica

Volumn 52, Issue 3, 2007, Pages 209-214

  Ruzicka F ^a   Hola V ^a   Votava, M ^a   Tejkalova R ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; CANDIDA; COLORIMETRY; CROSS INFECTION; DRUG EFFECT; FUNGEMIA; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOGENICITY;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; COLORIMETRY; CROSS INFECTION; DRUG RESISTANCE, FUNGAL; FUNGEMIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES;

CANDIDA PARAPSILOSIS;

EID: 34547368034     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931300     Document Type: Article

References (33)

1. ALMIRANTE B., RODRIGUEZ D., PARK B.J., CUENCA-ESTRELLA M., PLANES A.M., ALMELA M., MENSA J., SANCHEZ F., AYATS J., GIMENEZ M., SABALLS P., FRIDKIN S.K., MORGAN J., RODRIGUEZ-TUDELA J.L., WARNOCK D.W., PAHISSA A., Barcelona Candidemia Project Study Group: Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J.Clin.Microbiol. 43, 1829-1835 (2005).
2. ALMIRANTE B., RODRIGUEZ D., CUENCA- ESTRELLA M., ALMELA M., SANCHEZ F., AYATS J., ALONSO-TARRES C., RODRIGUEZ-TUDELA J.L., PAHISSA A.: Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J.Clin.Microbiol. 44, 1681-1685 (2006).
3. BACHMANN S.P., VANDEWALLE K., RAMAGE G., PATTERSON T.F., WICKES B.L., GRAYBILL J.R., LOPEZ-RIBOT J.L.: In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob.Agents Chemother. 46, 3591-3596 (2002).
4. BAKER C.N., TENOVER F.C.: Evaluation of Alamar colorimetric broth microdilution susceptibility testing method for staphylococci and enterococci. J.Clin.Microbiol. 34, 2654-2659 (1996).
5. BRANCHINI M.L., PFALLER M.A., RHINE- CHALBERG J., FREMPONG T., ISENBERG H.D.: Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J.Clin.Microbiol. 32, 452-456 (1994).
6. CHRISTENSEN G.D., SIMPSON W.A., YOUNGER J.J., BADDOUR L.M., BARRETT F.F., MELTON D.M., BEACHEY E.H.: Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J.Clin.Microbiol. 22, 996-1006 (1985).
7. DE BERNARDIS F., MONDELLO F., SAN MILLAN R., PONTON J., CASSONE A.: Biotyping and virulence properties of skin isolates of Candida parapsilosis. J.Clin.Microbiol. 37, 3481-3486 (1999).
8. DOUGLAS L.J.: Candida biofilms and their role in infection. Trends Microbiol. 11, 30-36 (2003).
9. FRIDKIN S.K., KAUFMAN D., EDWARDS J.R., SHETTY S., HORAN T.: Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 117, 1680-1687 (2006).
10. HAMAL P., DOSTÁL J., RACLAVSKÝ V., KRYLOVÁ M., PICHOVÁ I., HRUŠ KOVÁ-HEIDLNGSFELDOVÁ O.: Secreted aspartate proteinases, a virulence factor of Candida spp.: occurrence among clinical isolates. Folia Microbiol. 49, 491-496 (2004).
11. HAWSER S.P., DOUGLAS L.J.: Resistance of Candida albicans biofilms to antifungal agents In vitro. Antimicrob.Agents Chemother. 39, 2128-2131 (1995).
12. JAHN B., STUBEN A., BHAKDI S.: Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests. J.Clin.Microbiol. 34, 2039-2041 (1996).
13. KALKANCI A., BOZDAYI G., BIRI A., KUSTIMUR S.: Distribution of secreted aspartyl proteinases using a polymerase chain reaction assay with SAP specific primers in Candida albicans isolates. Folia Microbiol. 50, 409-414 (2005).
14. KRČMÉRY V. Jr., KOVAČIČ OVÁ G., Slovak fungemia study group: Longitudinal 10-year prospective survey of fungemia in Slovak Republic: trends in etiology in 310 episodes. Diagn.Microbiol.Infect.Dis. 36, 7-11 (2000).
15. KUHN D.M., GEORGE T., CHANDRA J., MUKHERJEE P.K., GHANNOUM M.A.: Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob.Agents Chemother. 46, 1773-1780 (2002).
16. LEWIS K.: Riddle of biofilm resistance. Antimicrob.Agents Chemother. 45, 999-1007 (2001).
17. MCGINLEY K.J., LARSON E.L., LEYDEN J.J.: Composition and density of microflora in the subungual space of the hand. J.Clin.Microbiol. 26, 950-953 (1988).
18. NCCLS (National Committee for Clinical Laboratory Standards): Reference method for broth dilution testing of yeasts, pp. 1-29 in Approved Standards, M27-A2, Vol. 22, 2nd ed. NCCLS, Wayne (USA) 2002.
19. NERO L.A., BELOTI V., BARROS M.A.F., SANTANA E.H.W., PEREIRA M.S., GUSMÃO V.V., MORAES L.B.: Assessment of the efficiency of SimPlate™ total plate count color indicator (TPC CI) to quantify mesophilic aerobic microorganisms in pasteurized milk. Brazil J.Microbiol. 33, 44-48 (2002).
20. O'BRIEN J., WILSON T., ORTON I., POGNAN F.: Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur.J.Biochem. 267, 5421-5426 (2000).
21. PALOMINO J.C., MARTIN A., CAMACHO M., GUERRA H., SWINGS J., PORTAELS F.: Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob.Agents Chemother. 46, 2720-2722 (2002).
22. PATERSON R.L., WEBSTER N.R.: Sepsis and the systemic inflammatory response syndrome. J.Roy.Coll.Surg.Edinburgh 45, 178-182 (2000).
23. PETTIT R.K., WEBER C.A., KEAN M.J., HOFFMANN H., PETTIT G.R., TAN R., FRANKS K.S., HORTON M.L.: Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob.Agents Chemother. 49, 2612-2617 (2005).
24. PFALLER M.A., BARRY A.L.: Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J.Clin.Microbiol. 32, 1992-1996 (1994).
25. RAMAGE G., WALLE K.V., WICKES B.L., LÓPEZ-RIBOT J.L.: Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob.Agents Chemother. 45, 2475-2479 (2001).
26. RAMAGE G., BACHMANN S., PATTERSON T.F., WICKES B.L., LÓPEZ-RIBOT J.L.: Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J.Antimicrob.Agents Chemother. 49, 973-980 (2002).
27. RASMUSSEN E.V.: Use of fluorescent redox indicators to evaluate cell proliferation and viability. In Vitro Mol.Toxicol. 12, 47-58 (1999).
28. RŮŽIČKA F., HOLÁ V., VOTAVA M., TEJKALOVÁ R., HORVÁT R., HEROLDOCÁ M., WOZNICOVÁ V.: Biofilm detection and the clinical significance of Staphylococcus epidermidis isolates. Folia Microbiol. 49, 596-600 (2004).
29. SAMARANAYAKE Y.H., YE J., YAU J.Y., CHEUNG B.P., SAMARANAYAKE L.P.: In vitro method to study antifungal perfusion in Candida biofilms. J. Clin.Microbiol. 43, 818-825 (2005).
30. SHIN J.H., KEE S.J., SHIN M.G., KIM S.H., SHIN D.H., LEE S.K., SUH S.P., RYANG D.W.: Biofilm production by isolates of Candida species recovered from non-neutropenic patients: comparison of bloodstream isolates with isolates from other sources. J.Clin. Microbiol. 40, 1244-1248 (2002).
31. TIBALLI R.N., HE X., ZARINS L.T., REVANKAR S.G., KAUFFMAN C.A.: Use of a colorimetric system for yeast susceptibility testing. J.Clin.Microbiol. 33, 915-917 (1995).
32. WALENCKA E., SADOWSKA B., RÓŻALSKA S., HRYNIEWICZ W., RÓŻALSKA B.: Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin. Folia Microbiol. 51, 381-386 (2006).
33. WEEMS J.J. Jr.: Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin.Infect. Dis. 14, 756-766 (1992).